Benefits of the Evidence-based approach

Accurate recruitment projections and timings

 

Site numbers are optimised and the number of poorly recruiting sites is reduced

 

Good relationships with Investigators and site staff are consolidated

 

Interest in the protocol is raised

 

Unnecessary protocol amendments are minimised

TEAMS CAN BE OVERCONFIDENT

and don’t think it is needed, but….No two protocols are ever exactly the same

 

Standard of Care may have changed

 

There may be new protocols competing for patients

LACK OF QUALIFIED RESOURCE?

Too labour intensive to do internally

CRAs may not have deep enough understanding of the disease

CDDI has senior medical experts to drive the process and engage in peer-to-peer discussion with Investigators

SITES WILL BE RELUCTANT TO DO IT?

In fact Investigators find the EbF process valuable

 

Sites are paid separately for this exercise

 

Focusses their attention on the protocol

UP-FRONT INVESTMENT OF TIME, RESOURCE AND BUDGET

The process takes around 3 months if the process is planned at an early stage. And, yes, there is an up-front investment to do the work.

Big savings can be made through fewer protocol amendments, more accurate prediction of recruitment, fewer sites and reduced project management costs
CDA AND CONTRACT TAKE A LONG TIME TO PUT IN PLACE

CDDI uses simplified CDAs and Letters of Agreement

Does your company need our services? Message us today!

  • CDDI

©2020 by Competitive Drug Development International Ltd.